New Zealand Pharmaceuticals Mergers & Acquisitions

New Zealand Pharmaceuticals M&A Summary

New Zealand Pharmaceuticals has acquired 1 company of its own.

The Company’s most targeted sectors include life science (100%).

M&A Summary

  • M&A Total Activity1
    • M&A Buy Activity1
  • Total Sectors Invested 1
  • Total Countries Invested 1
  • M&A Buy/Sell Connections 1

New Zealand Pharmaceuticals Ltd.

68 Weld Street, RD2,
Palmerston North, 4472
New Zealand,
+64 6 952 3800
www.nzp.co.nz

All (1) Buy (1) Sell (-)
Date Target Value
$mlns
Transaction Type Acquirer Seller SRC
Link
2009-09-02 Dextra Laboratories Ltd. · Life Science
Reading, United Kingdom · www.dextrauk.com

Dextra Laboratories Ltd. is involved in developing innovative solutions to minimise costs, reduce technology transfer issues and optimise robust route generation. The company supplies rare sugars, oligosaccharides and chiral molecules for medical research, diagnostics and pharmaceutical applications.

- Divestiture

New Zealand Pharmaceuticals Ltd.

Summit Therapeutics


Try Mergr Free — See This and 220,573+
Other Company and Investor Profiles Today

Try free. Full access. Cancel anytime.

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.

We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore an investment firm’s investment criteria, deal history, portfolio, and connections - organized to help you uncover opportunities and make informed decisions.

With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.8K Private Equity Firms
  • 214K M&A Transactions
  • 216K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.8K M&A Advisors
    (Investment Banks and Law Firms)
  • 83K M&A Contacts
    (PE and M&A Advisors)

What next?

Try Free

Full access to Mergr's investor, acquirer, and transaction data starts here.